Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

3 Downloads (Pure)

Access to Document

@article{45587ab9c5d54a06a991b0eae3ef2a53,

title = "Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sj{\"o}gren's disease",

author = "Dewi Rijnenberg and Safae Hamkour and Frank Redegeld and Helen Leavis and \{van Roon\}, Jo{\"e}l",

year = "2025",

month = nov,

doi = "10.1016/S2665-9913(25)00219-X",

language = "English",

volume = "7",

pages = "e754--e756",

journal = "The Lancet. Rheumatology",

publisher = "Elsevier Limited",

number = "11",

}

TY - JOUR

T1 - Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease

AU - Rijnenberg, Dewi

AU - Hamkour, Safae

AU - Redegeld, Frank

AU - Leavis, Helen

AU - van Roon, Joël

PY - 2025/11

Y1 - 2025/11

UR - https://www.scopus.com/pages/publications/105017327104

U2 - 10.1016/S2665-9913(25)00219-X

DO - 10.1016/S2665-9913(25)00219-X

M3 - Comment/Letter to the editor

AN - SCOPUS:105017327104

VL - 7

SP - e754-e756

JO - The Lancet. Rheumatology

JF - The Lancet. Rheumatology

IS - 11

ER -